These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26930065)

  • 1. Dynamic Modeling and Analysis of the Cross-Talk between Insulin/AKT and MAPK/ERK Signaling Pathways.
    Arkun Y
    PLoS One; 2016; 11(3):e0149684. PubMed ID: 26930065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dynamic analysis of IRS-PKR signaling in liver cells: a discrete modeling approach.
    Wu M; Yang X; Chan C
    PLoS One; 2009 Dec; 4(12):e8040. PubMed ID: 19956598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells.
    Alonso N; Diaz Nebreda A; Monczor F; Gutkind JS; Davio C; Fernandez N; Shayo C
    Biochim Biophys Acta; 2016 Sep; 1860(9):1998-2007. PubMed ID: 27316323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence resonance energy transfer based quantitative analysis of feedforward and feedback loops in epidermal growth factor receptor signaling and the sensitivity to molecular targeting drugs.
    Fujita Y; Komatsu N; Matsuda M; Aoki K
    FEBS J; 2014 Jul; 281(14):3177-92. PubMed ID: 24848561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK; Graab U; Fulda S
    Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.
    Saini KS; Loi S; de Azambuja E; Metzger-Filho O; Saini ML; Ignatiadis M; Dancey JE; Piccart-Gebhart MJ
    Cancer Treat Rev; 2013 Dec; 39(8):935-46. PubMed ID: 23643661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma.
    Milosevic Z; Pesic M; Stankovic T; Dinic J; Milovanovic Z; Stojsic J; Dzodic R; Tanic N; Bankovic J
    Transl Res; 2014 Nov; 164(5):411-23. PubMed ID: 25016932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of insulin resistance and glucose metabolism by interaction of PIM kinases and insulin receptor substrates.
    Aziz AUR; Farid S; Qin K; Wang H; Liu B
    Arch Physiol Biochem; 2020 May; 126(2):129-138. PubMed ID: 30270668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.
    Zhang X; Lavoie G; Méant A; Aubert L; Cargnello M; Haman A; Hoang T; Roux PP
    Mol Cell Biol; 2017 Apr; 37(7):. PubMed ID: 28096188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
    Tandon M; Chen Z; Pratap J
    J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of the MAPK and PI3K/Akt signaling pathways.
    C V SB; Babar SM; Song EJ; Oh E; Yoo YS
    Mol Cells; 2008 May; 25(3):397-406. PubMed ID: 18443420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.
    Carvalho CR; Carvalheira JB; Lima MH; Zimmerman SF; Caperuto LC; Amanso A; Gasparetti AL; Meneghetti V; Zimmerman LF; Velloso LA; Saad MJ
    Endocrinology; 2003 Feb; 144(2):638-47. PubMed ID: 12538627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.
    Kim KY; Park KI; Kim SH; Yu SN; Park SG; Kim YW; Seo YK; Ma JY; Ahn SC
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the MAPK/ERK Cell-Signaling Pathway in Uterine Smooth Muscle Cells of Women With Adenomyosis.
    Streuli I; Santulli P; Chouzenoux S; Chapron C; Batteux F
    Reprod Sci; 2015 Dec; 22(12):1549-60. PubMed ID: 26071388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
    Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
    Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells.
    Philippova M; Joshi MB; Pfaff D; Kyriakakis E; Maslova K; Erne P; Resink TJ
    Cardiovasc Res; 2012 Mar; 93(3):498-507. PubMed ID: 22235028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling.
    Luo M; Langlais P; Yi Z; Lefort N; De Filippis EA; Hwang H; Christ-Roberts CY; Mandarino LJ
    Endocrinology; 2007 Oct; 148(10):4895-905. PubMed ID: 17640984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of major elements of insulin signaling cascade in chicken adipose tissue: apparent insulin refractoriness.
    Dupont J; Métayer-Coustard S; Ji B; Ramé C; Gespach C; Voy B; Simon J
    Gen Comp Endocrinol; 2012 Mar; 176(1):86-93. PubMed ID: 22233773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.